|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW #650 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001-4973 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 290252-36
|
||||||||
|
6. House ID# 371850002
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Richard Bringewatt |
Date | 1/20/2017 3:09:22 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Continued to promote permanent extension of legislative authority for all types of Special Needs Plans in conjunction with related SNP-related provisions. Permanency and related provisions are important to provide stability for plans and states involved in advancing specialized managed care programs and for special needs individuals. This will also improve the viability of SNPs in fulfilling their Congressional established specialty care mandate.
Advocated for changes in methods used to measure SNP performance under STARS to more effectively account for influences of social, education, and economic factors that affect health and health outcomes for persons dually-eligible for Medicare and Medicaid beyond what exists for persons of higher income, education, and social and economic status. Current provisions do not fully account for factors that influence health and health-related outcomes.
Advocated for Congress to expedite the alignment of Medicare and Medicaid financing policy and oversight for persons dually-eligible for Medicare and Medicaid, including efforts to strengthen the role of the Dual Office to serve as a possible arbitrator in resolving key differences between Medicare and Medicaid. Advocated for provisions to improve efficiency in program administration and improve methods for serving frail elders, adults with disabilities, and other persons with complex medical conditions, such as HIV/AIDS, ESRD, and SMPM: These are the most costly and complex care subgroups of the dually-eligible population. Worked with the Medicare/Medicaid Coordination Office, Congress, and others toward better aligning Medicare and Medicaid policies and procedures for persons dually-eligible for Medicare and Medicaid.
Advocated for CMS to make additional improvements in the predictive accuracy of MA-HCC for high-risk/high-need beneficiaries. Conferred with the Government Accountability Office (GAO) about the study the Office is conducting on the CMS efforts to validate Medicare Advantage (MA) encounter data and its plans and time frames for using the data.
Advocated for specific improvements in policy and oversight for Institutional SNPs and Chronic Conditions SNPs to better enable them to address the unique needs of complex care beneficiaries.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rich |
Bringewatt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |